What 5 Analyst Ratings Have To Say About RadNet
Ratings for RadNet (NASDAQ:RDNT) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 2 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 2 | 1 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for RadNet, presenting an average target of $73.4, a high estimate of $88.00, and a low estimate of $60.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 16.21%.
Understanding Analyst Ratings: A Comprehensive Breakdown
The standing of RadNet among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Andrew Mok | Barclays | Lowers | Overweight | $60.00 | $74.00 |
| John Ransom | Raymond James | Lowers | Strong Buy | $65.00 | $85.00 |
| David Macdonald | Truist Securities | Lowers | Buy | $88.00 | $94.00 |
| Andrew Mok | Barclays | Lowers | Overweight | $74.00 | $85.00 |
| Brian Tanquilut | Jefferies | Lowers | Buy | $80.00 | $100.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to RadNet. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of RadNet compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of RadNet's stock. This comparison reveals trends in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of RadNet's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on RadNet analyst ratings.
Discovering RadNet: A Closer Look
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
Key Indicators: RadNet's Financial Health
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: RadNet's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 13.49%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: RadNet's net margin is impressive, surpassing industry averages. With a net margin of 1.12%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): RadNet's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.59%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): RadNet's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.16%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: RadNet's debt-to-equity ratio is below the industry average. With a ratio of 1.92, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
How Are Analyst Ratings Determined?
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.